Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis

Безопасность и эффективность внутривенной тромболитической терапии в расширенном временном окне до 24 часов: систематический обзор и метаанализ
Shadi R. Yaghi, Alejandro A. Rabinstein, David F. Kallmes, Sherief A. Ghozy, Seyed Behnam Jazayeri, Michelle A. Toruno, Yamama M. Mahmood, Omar M. Al‐Janabi
2024-10-29

acute ischemic strokeextended therapeutic windowintravenous thrombolytic therapyperfusion imagingsymptomatic intracranial hemorrhage
OBJECTIVE: About 25% of patients with acute ischemic stroke (AIS) present within the intravenous thrombolytic (IVT) therapeutic window of <4.5 h. This study is to elucidate the safety and efficacy of IVT in the extended therapeutic window (ETW) in patients with AIS. METHODS: Using PRISMA guidelines, a systematic review was conducted using PubMed, Embase, and Scopus. A rigorous risk of bias assessment was conducted using the RoB2 tool. Rates of excellent and good functional outcome (mRS 0-1 and mRS 0-2) at 90 days, symptomatic intracranial hemorrhage (sICH), and mortality at 90 days were pooled using generalized linear mixed model and compared with controls. Meta-analyses were conducted employing random-effect models with risk ratio (RR) and 95% confidence intervals (CIs). Subgroup analysis was performed to assess the effect of imaging modalities used for patient selection. RESULTS: Eight randomized controlled trials (n = 2221, 59% male) were included. At 90 days IVT showed higher rates of functional recovery: mRS 0-1: RR 1.21 95% CI 1.1-1.34, p < 0.001, and mRS 0-2: RR 1.11 95% CI 1.03-1.18, p = 0.004. Rate of mortality at 90 day was not different between groups: RR 1.17 95% CI 0.93-1.48, p = 0.17. However, the rate of sICH was higher among IVT group: RR 2.93 95% CI 1.53-5.6, p = 0.001. Subgroup analysis showed higher mRS 0-1 among patients who were selected based on perfusion imaging (p < 0.05). INTERPRETATION: The use of IVT in AIS in ETW is beneficial especially with the use of perfusion imaging for patients' selection.
1
A systematic review and meta-analysis of eight randomized controlled trials included 2,221 patients with acute ischemic stroke treated in the extended intravenous thrombolysis window.
2
Extended-window intravenous thrombolysis also improved good functional outcomes at 90 days (mRS 0–2; RR 1.11, 95% CI 1.03–1.18).
3
Extended-window intravenous thrombolysis improved excellent functional outcomes at 90 days (mRS 0–1; RR 1.21, 95% CI 1.10–1.34).
4
Ninety-day mortality did not differ significantly between extended-window thrombolysis and control groups (RR 1.17, 95% CI 0.93–1.48).
5
Symptomatic intracranial hemorrhage was significantly more frequent after extended-window thrombolysis (RR 2.93, 95% CI 1.53–5.60), while perfusion-imaging selection was associated with higher rates of excellent outcomes.

Patients with acute ischemic stroke treated with intravenous thrombolytic therapy in the extended therapeutic window up to 24 hours

The safety and efficacy of extended-window intravenous thrombolytic therapy, including functional recovery, symptomatic intracranial hemorrhage, and 90-day mortality, with the influence of perfusion-imaging-based patient selection

Publication Details
Publication Date
2024-10-29
Journal
Publisher
ISSN
Cited by
14
Access Type
Author Information
Authors
Shadi R. Yaghi
Alejandro A. Rabinstein
David F. Kallmes
Sherief A. Ghozy
Seyed Behnam Jazayeri
Michelle A. Toruno
Yamama M. Mahmood
Omar M. Al‐Janabi
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%